{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T05:04:07Z","timestamp":1746594247517,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Guangdong Esophageal Cancer Institute Science and Technology Program","award":["M201916"],"award-info":[{"award-number":["M201916"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>At present, clinical factors and hematological indicators have been proved to have great potential in predicting the prognosis of cancer patients, and no one has combined these two valuable indicators to establish a prognostic model for esophageal squamous cell carcinoma (ESCC) patients with stage T1-3N0M0 after R0 resection. To verify, we aimed to combine these potential indicators to establish a prognostic model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Stage T1-3N0M0 ESCC patients from two cancer centers (including training cohort: N\u2009=\u2009819, and an external validation cohort: N\u2009=\u2009177)\u2014who had undergone esophagectomy in 1995\u20132015 were included. We integrated significant risk factors for death events by multivariable logistic regression methods and applied them to the training cohort to build Esorisk. The parsimonious aggregate Esorisk score was calculated for each patient; the training set was divided into three prognostic risk classes according to the 33rd and 66th percentiles of the Esorisk score. The association of Esorisk with cancer-specific survival (CSS) was assessed using Cox regression analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The Esorisk model was: [10\u2009+\u20090.023\u2009\u00d7\u2009age\u2009+\u20090.517\u2009\u00d7\u2009drinking history\u2009\u2212\u20090.012\u2009\u00d7\u2009hemoglobin\u20130.042\u2009\u00d7\u2009albumin\u2009\u2212\u20090.032\u2009\u00d7\u2009lymph nodes]. Patients were grouped into three classes\u2014Class A (5.14\u20137.26, low risk), Class B (7.27\u20137.70, middle risk), and Class C (7.71\u20139.29, high risk). In the training group, five-year CSS decreased across the categories (A: 63%; B: 52%; C: 30%, Log-rank <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Similar findings were observed in the validation group. Additionally, Cox regression analysis showed that Esorisk aggregate score remained significantly associated with CSS in the training cohort and validation cohort after adjusting for other confounders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We combined the data of two large clinical centers, and comprehensively considered their valuable clinical factors and hematological indicators, established and verified a new prognostic risk classification that can predict CSS of stage T1-3N0M0 ESCC patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-023-02294-2","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T04:02:08Z","timestamp":1686715328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Establishment and validation of a prognostic risk classification for patients with stage T1-3N0M0 esophageal squamous cell carcinoma"],"prefix":"10.1186","volume":"18","author":[{"given":"Yang-Yu","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen-Hua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei-Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Qun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5956-8803","authenticated-orcid":false,"given":"Guo-Wei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"2294_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"2294_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2188\/jea.je20120162","volume":"23","author":"Y Lin","year":"2013","unstructured":"Lin Y, Totsuka Y, He Y, et al. Epidemiology of esophageal cancer in Japan and China. J Epidemiol. 2013;23:233\u201342. https:\/\/doi.org\/10.2188\/jea.je20120162.","journal-title":"J Epidemiol"},{"key":"2294_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/gutjnl-2014-308124","volume":"64","author":"M Arnold","year":"2015","unstructured":"Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64:381\u20137. https:\/\/doi.org\/10.1136\/gutjnl-2014-308124.","journal-title":"Gut"},{"key":"2294_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","volume":"154","author":"CC Abnet","year":"2018","unstructured":"Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154:360\u201373. https:\/\/doi.org\/10.1053\/j.gastro.2017.08.023.","journal-title":"Gastroenterology"},{"key":"2294_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.20892\/j.issn.2095-3941.2016.0093","volume":"14","author":"H Liang","year":"2017","unstructured":"Liang H, Fan JH, Qiao YL. Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med. 2017;14:33\u201341. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2016.0093.","journal-title":"Cancer Biol Med"},{"key":"2294_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332. https:\/\/doi.org\/10.3322\/caac.21338.","journal-title":"CA Cancer J Clin"},{"key":"2294_CR7","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.21037\/jtd.2019.07.68","volume":"11","author":"Y Feng","year":"2019","unstructured":"Feng Y, Wu N, Yan S, Wang X, Yang Y. Comparison of Ivor Lewis esophagectomy and Sweet esophagectomy for the treatment of middle-lower esophageal squamous cell carcinoma. J Thorac Dis. 2019;11:3584\u201392. https:\/\/doi.org\/10.21037\/jtd.2019.07.68.","journal-title":"J Thorac Dis"},{"key":"2294_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.radonc.2019.06.020","volume":"140","author":"S Yu","year":"2019","unstructured":"Yu S, Zhang W, Ni W, et al. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy. Radiother Oncol. 2019;140:159\u201366. https:\/\/doi.org\/10.1016\/j.radonc.2019.06.020.","journal-title":"Radiother Oncol"},{"key":"2294_CR9","doi-asserted-by":"publisher","first-page":"E282","DOI":"10.21037\/jtd.2017.03.39","volume":"9","author":"CL Donohoe","year":"2017","unstructured":"Donohoe CL, Phillips AW. Cancer of the esophagus and esophagogastric junction: an 8(th) edition staging primer. J Thorac Dis. 2017;9:E282\u20134. https:\/\/doi.org\/10.21037\/jtd.2017.03.39.","journal-title":"J Thorac Dis"},{"key":"2294_CR10","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1186\/s12885-019-6373-y","volume":"19","author":"Z Liu","year":"2019","unstructured":"Liu Z, Shi H, Chen L. Prognostic role of pre-treatment C-reactive protein\/albumin ratio in esophageal cancer: a meta-analysis. BMC Cancer. 2019;19:1161. https:\/\/doi.org\/10.1186\/s12885-019-6373-y.","journal-title":"BMC Cancer"},{"key":"2294_CR11","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.21037\/jtd.2019.07.30","volume":"11","author":"G Pirozzolo","year":"2019","unstructured":"Pirozzolo G, Gisbertz SS, Castoro C, van Berge Henegouwen MI, Scarpa M. Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis. J Thorac Dis. 2019;11:3136\u201345. https:\/\/doi.org\/10.21037\/jtd.2019.07.30.","journal-title":"J Thorac Dis"},{"key":"2294_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.21037\/atm.2019.07.63","volume":"7","author":"QX Shang","year":"2019","unstructured":"Shang QX, Yang YS, Hu WP, Yuan Y, Ji AF, Chen LQ. Prognostic significance and role of thoracic lymph node metastasis based on Chinese expert consensus in esophageal cancer. Ann Transl Med. 2019;7:381. https:\/\/doi.org\/10.21037\/atm.2019.07.63.","journal-title":"Ann Transl Med"},{"key":"2294_CR13","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.ejso.2018.04.011","volume":"44","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Fu S, He T, Yan Q, Di W, Wang J. Predicting prognosis in resected esophageal squamous cell carcinoma using a clinical nomogram and recursive partitioning analysis. Eur J Surg Oncol. 2018;44:1199\u2013204. https:\/\/doi.org\/10.1016\/j.ejso.2018.04.011.","journal-title":"Eur J Surg Oncol"},{"key":"2294_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.canlet.2019.11.011","volume":"469","author":"J Zhang","year":"2020","unstructured":"Zhang J, Luo A, Huang F, Gong T, Liu Z. SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4. Cancer Lett. 2020;469:390\u20138. https:\/\/doi.org\/10.1016\/j.canlet.2019.11.011.","journal-title":"Cancer Lett"},{"key":"2294_CR15","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41419-019-2114-z","volume":"10","author":"X Du","year":"2019","unstructured":"Du X, Xu Q, Pan D, et al. HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression. Cell Death Dis. 2019;10:873. https:\/\/doi.org\/10.1038\/s41419-019-2114-z.","journal-title":"Cell Death Dis"},{"issue":"11","key":"2294_CR16","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3390\/cells8111357","volume":"8","author":"ES Gruber","year":"2019","unstructured":"Gruber ES, Oberhuber G, Birner P, et al. The oncogene AF1Q is associated with WNT and STAT signaling and offers a novel independent prognostic marker in patients with resectable esophageal cancer. Cells. 2019;8(11):1357. https:\/\/doi.org\/10.3390\/cells8111357.","journal-title":"Cells"},{"key":"2294_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13019-020-01163-6","volume":"15","author":"LL Wu","year":"2020","unstructured":"Wu LL, Liu X, Huang W, et al. Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1\u20133N0M0 esophageal squamous cell carcinoma: a retrospective observational study. J Cardiothorac Surg. 2020;15:115. https:\/\/doi.org\/10.1186\/s13019-020-01163-6.","journal-title":"J Cardiothorac Surg"},{"key":"2294_CR18","doi-asserted-by":"publisher","first-page":"18122","DOI":"10.1038\/s41598-019-54731-9","volume":"9","author":"H Zhou","year":"2019","unstructured":"Zhou H, Dong J, Guo L, et al. The prognostic value of B7\u2013H6 in esophageal squamous cell carcinoma. Sci Rep. 2019;9:18122. https:\/\/doi.org\/10.1038\/s41598-019-54731-9.","journal-title":"Sci Rep"},{"key":"2294_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jamcollsurg.2014.11.028","volume":"220","author":"C Mariette","year":"2015","unstructured":"Mariette C, Gronnier C, Duhamel A, et al. Self-expanding covered metallic stent as a bridge to surgery in esophageal cancer: impact on oncologic outcomes. J Am Coll Surg. 2015;220:287\u201396. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2014.11.028.","journal-title":"J Am Coll Surg"},{"key":"2294_CR20","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1007\/s00268-015-3072-y","volume":"39","author":"G O'Grady","year":"2015","unstructured":"O\u2019Grady G, Hameed AM, Pang TC, et al. Patient selection for oesophagectomy: impact of age and comorbidities on outcome. World J Surg. 2015;39:1994\u20139. https:\/\/doi.org\/10.1007\/s00268-015-3072-y.","journal-title":"World J Surg"},{"key":"2294_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/2050640617751254","volume":"6","author":"SH Xie","year":"2018","unstructured":"Xie SH, Lagergren J. Social group disparities in the incidence and prognosis of oesophageal cancer. United European Gastroenterol J. 2018;6:343\u20138. https:\/\/doi.org\/10.1177\/2050640617751254.","journal-title":"United European Gastroenterol J"},{"key":"2294_CR22","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.tranon.2018.04.005","volume":"11","author":"C Shen","year":"2018","unstructured":"Shen C, Liu Z, Wang Z, et al. Building CT radiomics based nomogram for preoperative esophageal cancer patients lymph node metastasis prediction. Transl Oncol. 2018;11:815\u201324. https:\/\/doi.org\/10.1016\/j.tranon.2018.04.005.","journal-title":"Transl Oncol"},{"key":"2294_CR23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.dld.2018.08.002","volume":"50","author":"V Vendrely","year":"2018","unstructured":"Vendrely V, Launay V, Najah H, Smith D, Collet D, Gronnier C. Prognostic factors in esophageal cancer treated with curative intent. Dig Liver Dis. 2018;50:991\u20136. https:\/\/doi.org\/10.1016\/j.dld.2018.08.002.","journal-title":"Dig Liver Dis"},{"key":"2294_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13019-019-0981-0","volume":"14","author":"W Huang","year":"2019","unstructured":"Huang W, Wu L, Liu X, Long H, Rong T, Ma G. Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis. J Cardiothorac Surg. 2019;14:167. https:\/\/doi.org\/10.1186\/s13019-019-0981-0.","journal-title":"J Cardiothorac Surg"},{"key":"2294_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.annepidem.2016.11.004","volume":"27","author":"Y Lin","year":"2017","unstructured":"Lin Y, Totsuka Y, Shan B, et al. Esophageal cancer in high-risk areas of China: research progress and challenges. Ann Epidemiol. 2017;27:215\u201321. https:\/\/doi.org\/10.1016\/j.annepidem.2016.11.004.","journal-title":"Ann Epidemiol"},{"key":"2294_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijheh.2014.10.004","volume":"218","author":"WR Tang","year":"2015","unstructured":"Tang WR, Chen ZJ, Lin K, Su M, Au WW. Development of esophageal cancer in Chaoshan region, China: association with environmental, genetic and cultural factors. Int J Hyg Environ Health. 2015;218:12\u20138. https:\/\/doi.org\/10.1016\/j.ijheh.2014.10.004.","journal-title":"Int J Hyg Environ Health"},{"key":"2294_CR27","doi-asserted-by":"publisher","first-page":"e81670","DOI":"10.1371\/journal.pone.0081670","volume":"8","author":"S Liu","year":"2013","unstructured":"Liu S, Huang B, Huang H, et al. Patrilineal background of esophageal cancer and gastric cardia cancer patients in a Chaoshan high-risk area in China. PLoS ONE. 2013;8:e81670. https:\/\/doi.org\/10.1371\/journal.pone.0081670.","journal-title":"PLoS ONE"},{"key":"2294_CR28","doi-asserted-by":"publisher","unstructured":"Yang H, Liu H, Chen Y, et al; AME Thoracic Surgery Collaborative Group. Neoadjuvant chemoradiotherapy followed by surgeryversus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial. J Clin Oncol. 2018;36:2796\u20132803. https:\/\/doi.org\/10.1200\/JCO.2018.79.1483.","DOI":"10.1200\/JCO.2018.79.1483"},{"key":"2294_CR29","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.3892\/ol.2018.9747","volume":"17","author":"C Jiang","year":"2019","unstructured":"Jiang C, Zhu Y, Tang S, Zhang G, et al. High PD-L1 expression is associated with a favorable prognosis in patients with esophageal squamous cell carcinoma undergoing postoperative adjuvant radiotherapy. Oncol Lett. 2019;17:1626\u201334. https:\/\/doi.org\/10.3892\/ol.2018.9747.","journal-title":"Oncol Lett"},{"key":"2294_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ejca.2019.04.010","volume":"114","author":"A Noske","year":"2019","unstructured":"Noske A, M\u00f6bus V, Weber K, et al. Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node-positive study. Eur J Cancer. 2019;114:76\u201388. https:\/\/doi.org\/10.1016\/j.ejca.2019.04.010.","journal-title":"Eur J Cancer"},{"key":"2294_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12876-021-01636-5","volume":"21","author":"LL Wu","year":"2021","unstructured":"Wu LL, Ma QL, Huang W, et al. A prognostic model for stratification of stage IB\/IIA esophageal squamous cell carcinoma: a retrospective study. BMC Gastroenterol. 2021;21:59. https:\/\/doi.org\/10.1186\/s12876-021-01636-5.","journal-title":"BMC Gastroenterol"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-023-02294-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02294-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-023-02294-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T04:03:49Z","timestamp":1686715429000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-023-02294-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2294"],"URL":"https:\/\/doi.org\/10.1186\/s13019-023-02294-2","relation":{},"ISSN":["1749-8090"],"issn-type":[{"type":"electronic","value":"1749-8090"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"assertion":[{"value":"29 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Sun Yat-sen University Cancer Center (Approval number: YB2016-070) and complies with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors disclose no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}